203 related articles for article (PubMed ID: 30704674)
1. Optimal nanoparticle design for effective transport through the blood-brain barrier.
Park K
J Control Release; 2019 Feb; 295():290. PubMed ID: 30704674
[No Abstract] [Full Text] [Related]
2. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
Pinheiro RGR; Coutinho AJ; Pinheiro M; Neves AR
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769082
[TBL] [Abstract][Full Text] [Related]
3. Active Targeting Towards and Inside the Brain based on Nanoparticles: A Review.
Rabiei M; Kashanian S; Samavati SS; Jamasb S; McInnes SJP
Curr Pharm Biotechnol; 2020; 21(5):374-383. PubMed ID: 31793421
[TBL] [Abstract][Full Text] [Related]
4. Recent progress of drug nanoformulations targeting to brain.
Khan AR; Yang X; Fu M; Zhai G
J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive nanoparticle strategies for brain tumor targeting.
Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
[TBL] [Abstract][Full Text] [Related]
6. Nano carriers for drug transport across the blood-brain barrier.
Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
[TBL] [Abstract][Full Text] [Related]
7. ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier.
Dal Magro R; Ornaghi F; Cambianica I; Beretta S; Re F; Musicanti C; Rigolio R; Donzelli E; Canta A; Ballarini E; Cavaletti G; Gasco P; Sancini G
J Control Release; 2017 Mar; 249():103-110. PubMed ID: 28153761
[TBL] [Abstract][Full Text] [Related]
8. Strategies for drug delivery to the central nervous system by systemic route.
Kasinathan N; Jagani HV; Alex AT; Volety SM; Rao JV
Drug Deliv; 2015 May; 22(3):243-57. PubMed ID: 24471801
[TBL] [Abstract][Full Text] [Related]
9. The role of non-endothelial cells on the penetration of nanoparticles through the blood brain barrier.
Moura RP; Almeida A; Sarmento B
Prog Neurobiol; 2017 Dec; 159():39-49. PubMed ID: 28899762
[TBL] [Abstract][Full Text] [Related]
10. Colloidal polymeric nanoparticles and brain drug delivery.
Khalil NM; Mainardes RM
Curr Drug Deliv; 2009 Jul; 6(3):261-73. PubMed ID: 19604140
[TBL] [Abstract][Full Text] [Related]
11. Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system.
Crawford L; Rosch J; Putnam D
J Control Release; 2016 Oct; 240():251-266. PubMed ID: 26724368
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis.
Nair KGS; Ramaiyan V; Sukumaran SK
Inflammopharmacology; 2018 Jun; 26(3):675-684. PubMed ID: 29582240
[TBL] [Abstract][Full Text] [Related]
13. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.
Fan Y; Chen M; Zhang J; Maincent P; Xia X; Wu W
Crit Rev Ther Drug Carrier Syst; 2018; 35(5):433-467. PubMed ID: 30317945
[TBL] [Abstract][Full Text] [Related]
14. [Possibility of therapy of brain functions by intranasal administration].
Kashiwayanagi M; Iseki K
Yakugaku Zasshi; 2012; 132(11):1245-6. PubMed ID: 23123714
[No Abstract] [Full Text] [Related]
15. Two Important Polysaccharides as Carriers for Drug Delivery.
Huang G; Chen Y; Li Y; Huang D; Han J; Yang M
Mini Rev Med Chem; 2015; 15(13):1103-9. PubMed ID: 26156418
[TBL] [Abstract][Full Text] [Related]
16. Designing drug-delivery systems for the nervous system using nanotechnology: opportunities and challenges.
Liu-Snyder P; Webster TJ
Expert Rev Med Devices; 2006 Nov; 3(6):683-7. PubMed ID: 17280531
[No Abstract] [Full Text] [Related]
17. Nasal-to-CNS drug delivery: where are we now and where are we heading? An industrial perspective.
Landis MS; Boyden T; Pegg S
Ther Deliv; 2012 Feb; 3(2):195-208. PubMed ID: 22834197
[TBL] [Abstract][Full Text] [Related]
18. Modulation of blood-brain barrier permeability.
Rapoport SI
J Drug Target; 1996; 3(6):417-25. PubMed ID: 8863135
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of nanoparticle transport through in vitro blood-brain barrier models.
Berg C
Tissue Barriers; 2016; 4(1):e1143545. PubMed ID: 27141425
[TBL] [Abstract][Full Text] [Related]
20. Learning from our failures in blood-brain permeability: what can be done for new drug discovery?
Martel S
Expert Opin Drug Discov; 2015 Mar; 10(3):207-11. PubMed ID: 25658294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
